American Portfolios Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
American Portfolios Advisors's NVS Position: Q3 2022 in Review
American Portfolios Advisors increased its Novartis (NVS) stake by 5.3% in Q3 2022, buying an estimated $26K and bringing the position to 6,224 shares worth $473K. The position accounts for 0.02% of the portfolio, ranked #665.
American Portfolios Advisors first reported a position in NVS in Q4 2017 and has held it in 20 quarters since. The position peaked at $666K in Q4 2019. 1,088 funds tracked by Wall St. Rank hold NVS as of Q3 2022.
- American Portfolios Advisors held 6,224 shares of Novartis worth $473K as of Q3 2022.
- American Portfolios Advisors bought 314 Novartis shares in Q3 2022, an estimated $26K.
- Novartis made up 0.02% of American Portfolios Advisors's portfolio in Q3 2022, its #665 holding.
- American Portfolios Advisors first reported a position in Novartis in Q4 2017 and has held it in 20 quarters since.
- American Portfolios Advisors's Novartis position peaked at $666K in Q4 2019.
- 1,088 funds tracked by Wall St. Rank held Novartis as of Q3 2022.
Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.